What patients really want: involvement
Interviewee/Contributor
Pierre Meulien
Organisation
Innovative Medicines Initiative
Drug discovery
A meeting of minds at AstraZeneca
Interviewee/Contributor
José Baselga
Organisation
AstraZeneca Plc
Interview: The metabolic route to drug discovery
Interviewee/Contributor
David Moller
Organisation
Poxel SA
Interview: Targeting diseases of cortisol deficiency
Interviewee/Contributor
Martin Whitaker
Organisation
Diurnal Group Plc
The changing landscape for haemophilia treatment
Interviewee/Contributor
Victoria English
Organisation
MedNous
Hope rekindled for Alzheimer's disease treatment
Interviewee/Contributor
Andrea Pfeifer
Organisation
AC Immune SA
Discovery suggests new approach to liver disease
Interviewee/Contributor
Peter Charlish
Organisation
MedNous
New treatments for macular degeneration
Interviewee/Contributor
Peter Charlish
Organisation
MedNous
RNA epigenetics is coming of age
Interviewee/Contributor
Oliver Rausch
Organisation
Storm Therapeutics Ltd
Ion channel drug discovery and modern medicine
Interviewee/Contributor
Marc Rogers
Organisation
Metrion Biosciences Ltd